Tag: metastatic BCC

Home / metastatic BCC

Categories

Cemiplimab-rwlc has been approved by the FDA for the treatment of locally progressed and metastatic basal cell carcinoma

August 20, 2021: The FDA has given cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) regular approval for patients with locally advanced basal cell carcinoma (laBCC) who have previously been ...
metastatic-bcc

We Are Online! Chat With Us!
Scan the code